Interventional Cardiology

At Biosensors, we strive to make an impact in patients’ lives by continually investing in and developing pioneering medical technology. Being at the forefront of new and innovative solutions helps us respond to the changing needs of the interventional cardiology market. We are the first company to offer a commercially available abluminal drug-eluting stent with a biodegradable limus technology on our proven stent platform, the S-Stent™.

We have demonstrated and proven our commitment to innovation in interventional cardiology as we were the:

• First cardiology device company to develop a proprietary drug specifically designed for coronary stent use — Biolimus A9™ (BA9™); the compound is proprietary to Biosensors and is not licensed from a pharmaceutical company
• First company to successfully develop and launch an abluminal biodegradable polymer DES with a coating absorbed after 6 to 9 months*.
• First company to sponsor a randomized head-to-head comparison against a sirolimus eluting stent in an all-comers setting.
• First company to prove non-inferiority on a clinical endpoint against CYPHER® SELECT™ ¹

Our interventional cardiology products are designed
to optimize your patient outcomes

Our new generation drug-eluting stent was created using the most advanced medical technology in its field. It offers patients many benefits by combining:

• Proven safety of a DES with
  • An abluminal coating that reduces systemic drug exposure, provides more targeted drug release and promotes an endothelial coverage similar to a bare metal stent (BMS)
  • A biodegradable polymer that is absorbed after 6 to 9 months*
• Proven efficacy of our drug, BA9™, that has 10 times more lipophilicity than sirolimus, resulting  in a more targeted release to the vessel wall
• Proven flexibility with advance stent design

Based on the advanced design technology behind our proprietary S-Stent™ platform, Gazelle™² is our bare metal stent (BMS) that provides cardiologists with:

• Flexible stent design with the Quatrature Link™ technology for excellent deliverability

Biosensors’ balloon dilatation catheter achieves the right balance of push-track-cross to meet clinical needs

• The MultiPleat™ folding technology provides excellent cross and re-cross properties to facilitate use in complex procedures.